Ablative radiotherapy for liver tumors using stereotactic MRI-guidance: A prospective phase I trial
- 1 May 2022
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 170, 14-20
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Institutional experience in the treatment of colorectal liver metastases with stereotactic body radiation therapyReports of Practical Oncology and Radiotherapy, 2017
- Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastasesPractical Radiation Oncology, 2016
- Gadoxetate for direct tumor therapy and tracking with real-time MRI-guided stereotactic body radiation therapy of the liverRadiotherapy and Oncology, 2016
- Stereotactic Body Radiotherapy for Primary Hepatocellular CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver MetastasesJournal of Clinical Oncology, 2009
- Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaJournal of Clinical Oncology, 2008
- Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines CureJournal of Clinical Oncology, 2007
- Epidemiology of Primary and Secondary Liver CancersSeminars in Interventional Radiology, 2006
- Phase II study on stereotactic body radiotherapy of colorectal metastasesActa Oncologica, 2006
- The Natural History of Primary and Secondary Malignant Tumors of the Liver IIDigestion, 1969